 |
p-PKR (Thr 446) Antibody: sc-16565 |
| Datasheet |
|
- goat polyclonal IgG, 200 µg/ml; also available as rabbit IgG, 200 µg/ml, sc-16565-R
- epitope corresponding to a short amino acid sequence containing phosphorylated Thr 446 of PKR of human origin
- recommended for detection of Thr 446 phosphorylated PKR of human origin by WB, IP, IF and ELISA
- blocking peptide, sc-16565 P
|
|
| |
Ordering InformationProduct Citations
Recommended Support Products:
(click button of application of choice)
| |
| Species |
Gene Name |
Gene ID |
Chromosome Location |
Isoform (mRNA) Accession # |
Protein Accession # |
OMIM™ Number |
| Human |
EIF2AK2 |
5610 |
2p22.2 |
NM_002759 |
P19525
|
176871 |
| |
PKR Background Information An interferon-inducible, RNA-dependent protein serine/threonine kinase, PKR has various designations. Mouse PKR is known as DAI, dsJ, PI kinase, p65, p67 or TIK, whereas human PKR is known as p68 or p69. PKR phosphorylates its substrate, a subunit of protein synthesis initiation factor eIF-2 on Ser 51 to inhibit translation. PKR contains two dsRNA binding motifs required for its activation by dsRNA. Three kinds of regulation of PKR enzymatic activity occur, and these include transcriptional regulation in response to interferon, an autoregulatory mechanism controlling PKR expression at the level of translation, and posttranslational regulation by RNA mediated autophosphorylation. Human PKR contains at least 15 autophosphorylation sites, but only Thr-446 and Thr-451 in the activation loop are critical for its kinase activity. Thr-446 is the in vivo autophosphorylation site of PKR. Mutation of threonine to alanine at position 446 substantially reduces PKR function, and mutant kinase containing Ala-451 is completely inactive.
| p-PKR (Thr 446) Product Citations |
See how others have used p-PKR (Thr 446): sc-16565 antibody and or p-PKR (Thr 446) antibody conjugates.
2 total citations Loading citations.
|
| |
|
 |
|
p-PKR (Thr 446)
Click on image to enlarge
|
|
p-PKR (Thr 446)-R: sc-16565-R. Western blot analysis of PKR phosphorylation in untreated (A), calyculin A and IFNα treated (B) and calyculin A, IFNα and lambda protein phosphatase treated (C) HeLa whole cell lysates.
Western blot analysis of PKR phosphorylation in untreated (A,D), calyculin treated (B,E) and calyculin and lambda protein phosphatase treated (C,F) HeLa whole cell lysates. Antibodies tested include p-PKR (Thr 446)-R: sc-16565-R (A,B,C) and PKR (M-515): sc-1702 (D,E,F).
|
|
Download
|
|